Overactive Bladder clinical trials at UCSF
1 research study open to eligible people
open to eligible females ages 60 years and up
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
San Francisco, California and other locations
Our lead scientists for Overactive Bladder research studies include Alison Huang.